ImmunityBio, Inc. (IBRX)

NASDAQ: IBRX · Real-Time Price · USD

8.19

+0.04 (0.49%)

May 14, 2026, 11:03 AM EDT - Market open

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
United States Revenue	140.68M	113.01M	14.21M
United States Revenue Growth	24.48%	695.06%	45751.61%
Europe Revenue	-	278.00K	531.00K
Europe Revenue Growth	-	-47.65%	-10.15%
Revenue (Other)	302.00K	-	-
Revenue (Total)	140.98M	113.29M	14.75M
Revenue (Total) Growth	24.44%	668.32%	2270.58%

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Product Revenue	140.64M	112.98M	14.15M
Product Revenue Growth	24.48%	698.46%	-
Other Revenue	337.00K	306.00K	595.00K
Other Revenue Growth	10.13%	-48.57%	-4.34%
Revenue (Total)	140.98M	113.29M	14.75M
Revenue (Total) Growth	24.44%	668.32%	2270.58%

Updated May 7, 2026. Data Source: Fiscal.ai.